No Data
EU Panel Reconfirms Recommendation for BioArctic Partner's Alzheimer's Drug
Biogen, Eisai Alzheimer's Drug Sent Back for EU Nod After Safety Review
Biogen, Eisai Say EMA Panel Reaffirms Positive Opinion on Lecanemab
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○ List of stocks for Buy conversion in the market Code Stock Name Final Price SAR Main Board <1419> Tamahome 3420 3270 <1780> Yamauchi 13101259 <2211> Fujiya 22812221 <2590> DyDo 29742883 <2692> Itochu Foods 75907350 <2734> Sara 808753 <2809> Kewpie 28472779 <3036> Howmet Aerospace Inc
The Nikkei average is down about 320 yen, selling leading followed by a slight decline = 25th morning session.
On the 25th, at around 10:02 AM, the Nikkei Average was trading approximately 320 yen lower than the previous week, around 38,450 yen. At 9:20 AM, it dropped to 38,131.79 yen, down 645.15 yen. In the U.S. stock market on the 24th, although the NY Dow slightly rebounded, the Nasdaq Composite Index fell for the third consecutive day. Additionally, the SOX Index, which is influenced by Semiconductors and has a high contribution to the Nikkei Average, also continued to decline, resulting in selling pressure on Japanese stocks.
$19.6 Bn Alzheimer's Disease Global Markets, Therapeutics and Diagnostics to 2029, Profiles of Leading Players - AbbVie, Biogen, Eisai Co, Eli Lilly and Co., and F. Hoffmann-La Roche - ResearchAndMarkets.com
J Servai (JLAPT) : $Target Hospitality (TH.US)$ ...